OP-006 Quality of Life in Patients With Non-Valvular Atrial Fibrillation: Results From TREQ-AF Study
According to AF types, 43.8% had permanent AF, 32.9% had paroxysmal AF, and 23.3% had persistent AF. Present 91 0.802±0.167 93 0.646±0.258
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2015-03, Vol.115, p.S3-S3 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S3 |
|---|---|
| container_issue | |
| container_start_page | S3 |
| container_title | The American journal of cardiology |
| container_volume | 115 |
| creator | Özin, Bülent Aytemir, Kudret Arslan, Özgür Özcan, Türkay Kanadaşı, Mehmet Demir, Mesut Gökçe, Mustafa Sucu, Mehmet Murat Özdemir, Murat Yiğit, Zerrin Yavuzkır, Mustafa Ferzeyn Oto, Ali |
| description | According to AF types, 43.8% had permanent AF, 32.9% had paroxysmal AF, and 23.3% had persistent AF. Present 91 0.802±0.167 93 0.646±0.258 |
| doi_str_mv | 10.1016/j.amjcard.2015.01.052 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1662460775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914915001472</els_id><sourcerecordid>3621792921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1855-45efdf02e05fc77ddb956751c859cb6d1a05c34e196ced083b78eec1b83f96ad3</originalsourceid><addsrcrecordid>eNqFkU9r3DAQxUVpodu0HyEg6NnujG3Jdg8tS8i2haX5nxyFLI2pXK2dSHZgv321bKDQS0_DwJs3M7_H2ClCjoDy05Dr3WB0sHkBKHLAHETxiq2wqdsMWyxfsxUAFFmLVfuWvYtxSC2ikCtmLy4zAMmvFu3dvOdTz7euJ-5GfqlnR-Mc-YObf_Gf05jda_-8eB34eg5Oe75xXXDeJ900fubXFBef5Jsw7fjt9flVtt7wm3mx-_fsTa99pA8v9YTdbc5vz75n24tvP87W28xgI0RWCeptDwWB6E1dW9u1QtYCTSNa00mLGoQpK8JWGrLQlF3dEBnsmrJvpbblCft49H0M09NCcVbDtIQxrVQoZVFJqGuRVOKoMmGKMVCvHoPb6bBXCOoAVA3qBag6AFWAKgFNc1-Pc5ReeHYUVDQJUDrFBTKzspP7r8OXfxyMd6Mz2v-mPcW_x6pYKFA3h9AOmaFIcVV1Uf4BQHyUhg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1662460775</pqid></control><display><type>article</type><title>OP-006 Quality of Life in Patients With Non-Valvular Atrial Fibrillation: Results From TREQ-AF Study</title><source>Elsevier ScienceDirect Journals</source><creator>Özin, Bülent ; Aytemir, Kudret ; Arslan, Özgür ; Özcan, Türkay ; Kanadaşı, Mehmet ; Demir, Mesut ; Gökçe, Mustafa ; Sucu, Mehmet Murat ; Özdemir, Murat ; Yiğit, Zerrin ; Yavuzkır, Mustafa Ferzeyn ; Oto, Ali</creator><creatorcontrib>Özin, Bülent ; Aytemir, Kudret ; Arslan, Özgür ; Özcan, Türkay ; Kanadaşı, Mehmet ; Demir, Mesut ; Gökçe, Mustafa ; Sucu, Mehmet Murat ; Özdemir, Murat ; Yiğit, Zerrin ; Yavuzkır, Mustafa Ferzeyn ; Oto, Ali</creatorcontrib><description>According to AF types, 43.8% had permanent AF, 32.9% had paroxysmal AF, and 23.3% had persistent AF. Present 91 0.802±0.167 93 0.646±0.258 <0.001 Absent 38 0.832±0.151 38 0.780±0.212 0.045 Table The EuroQol five-dimensional questionnaire scores of the patients EQ-5D, EuroQol five-dimensional questionnaire; SD, standard deviation; AF, atrial fibrillation. * Confidence interval is set at 95%. ** Among the patients using oral anticoagulants, 97.4% and 97.5% were on warfarin therapy at baseline and 12th month, respectively.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2015.01.052</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Anticoagulants ; Cardiovascular ; Drug therapy ; Heart attacks ; Quality of life</subject><ispartof>The American journal of cardiology, 2015-03, Vol.115, p.S3-S3</ispartof><rights>2015</rights><rights>Copyright Elsevier Limited Mar 16, 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914915001472$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Özin, Bülent</creatorcontrib><creatorcontrib>Aytemir, Kudret</creatorcontrib><creatorcontrib>Arslan, Özgür</creatorcontrib><creatorcontrib>Özcan, Türkay</creatorcontrib><creatorcontrib>Kanadaşı, Mehmet</creatorcontrib><creatorcontrib>Demir, Mesut</creatorcontrib><creatorcontrib>Gökçe, Mustafa</creatorcontrib><creatorcontrib>Sucu, Mehmet Murat</creatorcontrib><creatorcontrib>Özdemir, Murat</creatorcontrib><creatorcontrib>Yiğit, Zerrin</creatorcontrib><creatorcontrib>Yavuzkır, Mustafa Ferzeyn</creatorcontrib><creatorcontrib>Oto, Ali</creatorcontrib><title>OP-006 Quality of Life in Patients With Non-Valvular Atrial Fibrillation: Results From TREQ-AF Study</title><title>The American journal of cardiology</title><description>According to AF types, 43.8% had permanent AF, 32.9% had paroxysmal AF, and 23.3% had persistent AF. Present 91 0.802±0.167 93 0.646±0.258 <0.001 Absent 38 0.832±0.151 38 0.780±0.212 0.045 Table The EuroQol five-dimensional questionnaire scores of the patients EQ-5D, EuroQol five-dimensional questionnaire; SD, standard deviation; AF, atrial fibrillation. * Confidence interval is set at 95%. ** Among the patients using oral anticoagulants, 97.4% and 97.5% were on warfarin therapy at baseline and 12th month, respectively.</description><subject>Anticoagulants</subject><subject>Cardiovascular</subject><subject>Drug therapy</subject><subject>Heart attacks</subject><subject>Quality of life</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkU9r3DAQxUVpodu0HyEg6NnujG3Jdg8tS8i2haX5nxyFLI2pXK2dSHZgv321bKDQS0_DwJs3M7_H2ClCjoDy05Dr3WB0sHkBKHLAHETxiq2wqdsMWyxfsxUAFFmLVfuWvYtxSC2ikCtmLy4zAMmvFu3dvOdTz7euJ-5GfqlnR-Mc-YObf_Gf05jda_-8eB34eg5Oe75xXXDeJ900fubXFBef5Jsw7fjt9flVtt7wm3mx-_fsTa99pA8v9YTdbc5vz75n24tvP87W28xgI0RWCeptDwWB6E1dW9u1QtYCTSNa00mLGoQpK8JWGrLQlF3dEBnsmrJvpbblCft49H0M09NCcVbDtIQxrVQoZVFJqGuRVOKoMmGKMVCvHoPb6bBXCOoAVA3qBag6AFWAKgFNc1-Pc5ReeHYUVDQJUDrFBTKzspP7r8OXfxyMd6Mz2v-mPcW_x6pYKFA3h9AOmaFIcVV1Uf4BQHyUhg</recordid><startdate>20150316</startdate><enddate>20150316</enddate><creator>Özin, Bülent</creator><creator>Aytemir, Kudret</creator><creator>Arslan, Özgür</creator><creator>Özcan, Türkay</creator><creator>Kanadaşı, Mehmet</creator><creator>Demir, Mesut</creator><creator>Gökçe, Mustafa</creator><creator>Sucu, Mehmet Murat</creator><creator>Özdemir, Murat</creator><creator>Yiğit, Zerrin</creator><creator>Yavuzkır, Mustafa Ferzeyn</creator><creator>Oto, Ali</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20150316</creationdate><title>OP-006 Quality of Life in Patients With Non-Valvular Atrial Fibrillation: Results From TREQ-AF Study</title><author>Özin, Bülent ; Aytemir, Kudret ; Arslan, Özgür ; Özcan, Türkay ; Kanadaşı, Mehmet ; Demir, Mesut ; Gökçe, Mustafa ; Sucu, Mehmet Murat ; Özdemir, Murat ; Yiğit, Zerrin ; Yavuzkır, Mustafa Ferzeyn ; Oto, Ali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1855-45efdf02e05fc77ddb956751c859cb6d1a05c34e196ced083b78eec1b83f96ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anticoagulants</topic><topic>Cardiovascular</topic><topic>Drug therapy</topic><topic>Heart attacks</topic><topic>Quality of life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Özin, Bülent</creatorcontrib><creatorcontrib>Aytemir, Kudret</creatorcontrib><creatorcontrib>Arslan, Özgür</creatorcontrib><creatorcontrib>Özcan, Türkay</creatorcontrib><creatorcontrib>Kanadaşı, Mehmet</creatorcontrib><creatorcontrib>Demir, Mesut</creatorcontrib><creatorcontrib>Gökçe, Mustafa</creatorcontrib><creatorcontrib>Sucu, Mehmet Murat</creatorcontrib><creatorcontrib>Özdemir, Murat</creatorcontrib><creatorcontrib>Yiğit, Zerrin</creatorcontrib><creatorcontrib>Yavuzkır, Mustafa Ferzeyn</creatorcontrib><creatorcontrib>Oto, Ali</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Özin, Bülent</au><au>Aytemir, Kudret</au><au>Arslan, Özgür</au><au>Özcan, Türkay</au><au>Kanadaşı, Mehmet</au><au>Demir, Mesut</au><au>Gökçe, Mustafa</au><au>Sucu, Mehmet Murat</au><au>Özdemir, Murat</au><au>Yiğit, Zerrin</au><au>Yavuzkır, Mustafa Ferzeyn</au><au>Oto, Ali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OP-006 Quality of Life in Patients With Non-Valvular Atrial Fibrillation: Results From TREQ-AF Study</atitle><jtitle>The American journal of cardiology</jtitle><date>2015-03-16</date><risdate>2015</risdate><volume>115</volume><spage>S3</spage><epage>S3</epage><pages>S3-S3</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>According to AF types, 43.8% had permanent AF, 32.9% had paroxysmal AF, and 23.3% had persistent AF. Present 91 0.802±0.167 93 0.646±0.258 <0.001 Absent 38 0.832±0.151 38 0.780±0.212 0.045 Table The EuroQol five-dimensional questionnaire scores of the patients EQ-5D, EuroQol five-dimensional questionnaire; SD, standard deviation; AF, atrial fibrillation. * Confidence interval is set at 95%. ** Among the patients using oral anticoagulants, 97.4% and 97.5% were on warfarin therapy at baseline and 12th month, respectively.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.amjcard.2015.01.052</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2015-03, Vol.115, p.S3-S3 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_journals_1662460775 |
| source | Elsevier ScienceDirect Journals |
| subjects | Anticoagulants Cardiovascular Drug therapy Heart attacks Quality of life |
| title | OP-006 Quality of Life in Patients With Non-Valvular Atrial Fibrillation: Results From TREQ-AF Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T10%3A14%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OP-006%20Quality%20of%20Life%20in%20Patients%20With%20Non-Valvular%20Atrial%20Fibrillation:%20Results%20From%20TREQ-AF%20Study&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=%C3%96zin,%20B%C3%BClent&rft.date=2015-03-16&rft.volume=115&rft.spage=S3&rft.epage=S3&rft.pages=S3-S3&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2015.01.052&rft_dat=%3Cproquest_cross%3E3621792921%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1662460775&rft_id=info:pmid/&rft_els_id=S0002914915001472&rfr_iscdi=true |